| Literature DB >> 27402349 |
Kei Long Cheung1, Ben F M Wijnen2,3, Ilene L Hollin4, Ellen M Janssen4, John F Bridges4, Silvia M A A Evers2, Mickael Hiligsmann2.
Abstract
INTRODUCTION: Best-worst scaling (BWS) is becoming increasingly popular to elicit preferences in health care. However, little is known about current practice and trends in the use of BWS in health care. This study aimed to identify, review and critically appraise BWS in health care, and to identify trends over time in key aspects of BWS.Entities:
Mesh:
Year: 2016 PMID: 27402349 PMCID: PMC5110583 DOI: 10.1007/s40273-016-0429-5
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981
Fig. 1Examples of a best–worst scaling (BWS) object case, b BWS profile case and c BWS multi-profile case
Fig. 2Flow chart of the study identification process. BWS best–worst scaling
Fig. 3Cumulative numbers of best–worst scaling (BWS) studies by year and by BWS case type
Characteristics and quality of best–worst scaling (BWS) studies conducted in health care
| Studiesa | Country/region | Year |
| Number of factors | Number of choice tasks | Number of factors per choice task | PREFS checklist scoresb | Total PREFS score | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
| ||||||||
| BWS object case | ||||||||||||
| Louviere and Flynn [ | Australia | 2010 | 204 | 15 | 15 | 8 | 1 | 0 | 1 | 1 | 1 | 4 |
| Kurkjian et al. (1) [ | USA | 2011 | 204 | 11 | NR | 4 | 1 | 0 | 0 | 1 | 0 | 2 |
| Kurkjian et al. (2) [ | USA | 2011 | 164 | 11 | NR | 4 | 1 | 0 | 0 | 1 | 0 | 2 |
| Gallego et al. [ | International | 2012 | 120 | 11 | 11 | 5 | 1 | 0 | 1 | 0 | 1 | 3 |
| Marti [ | Switzerland | 2012 | 376 | 15 | 16 | 11 | 1 | 0 | 1 | 0 | 1 | 4 |
| Mazanov et al. [ | Australia | 2012 | 168 | 11 | 11 | 5 | 1 | 0 | 1 | 1 | 1 | 3 |
| Silverman et al. [ | USA | 2013 | 367 | 39 | NR | NR | 1 | 0 | 0 | 1 | 1 | 3 |
| Cozmuta et al. [ | USA | 2014 | 118 | 23 | 20 | 5 | 1 | 0 | 1 | 1 | 1 | 4 |
| Ejaz et al. [ | USA | 2014 | 214 | 16 | 16 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| Hauber et al. [ | USA, Germany | 2014 | 803 | 10 | 5 | 5 | 1 | 0 | 1 | 1 | 1 | 4 |
| Hofstede et al. (1) [ | Netherlands | 2014 | 246 | 53 | NR | 6 | 1 | 0 | 0 | 0 | 1 | 4 |
| Hofstede et al. (2) [ | Netherlands | 2014 | 155 | 35 | NR | 6 | 1 | 0 | 0 | 0 | 1 | 4 |
| Torbica et al. [ | West Africa | 2014 | 89 | 11 | 11 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| van Til et al. [ | Netherlands, Canada | 2014 | 15 | 14 | 12 | 4 | 1 | 1 | 0 | 1 | 0 | 3 |
| Yuan et al. (1) [ | USA | 2014 | 273 | 10 | 15 | 3 | 1 | 0 | 1 | 0 | 0 | 2 |
| Yuan et al. (2) [ | USA | 2014 | 206 | 9 | 14 | 3 | 1 | 0 | 1 | 0 | 0 | 2 |
| Beusterien et al. [ | USA, UK | 2015 | 245 | 13 | 13 | 4 | 1 | 0 | 1 | 1 | 1 | 4 |
| Fraenkel et al. [ | USA | 2015 | 162 | 11 | 11 | 5 | 1 | 0 | 1 | 0 | 0 | 2 |
| Hashim et al. [ | UK | 2015 | 139 | 13 | 13 | 4 | 1 | 0 | 0 | 1 | 0 | 3 |
| Malhotra et al. [ | Singapore | 2015 | 285 | 9 | 12 | 3 | 0 | 0 | 1 | 1 | 0 | 3 |
| Narurkar et al. [ | USA | 2015 | 603 | 14 | 14 | 3 | 1 | 0 | 1 | 0 | 0 | 2 |
| Peay et al. [ | USA | 2015 | 119 | 16 | 16 | 6 | 1 | 0 | 1 | 1 | 0 | 3 |
| Ross et al. [ | USA | 2015 | 25 | 16 | 16 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| Wittenberg et al. [ | USA | 2015 | 30 | 11 | 11 | 5 | 1 | 0 | 1 | NA | NA | 2 |
| Yan et al. [ | USA | 2015 | 110 | 10 | 11 | 5 | 1 | 0 | 1 | 1 | 1 | 4 |
| Yu et al. [ | USA | 2015 | 182 | 6 | 10 | 3 | 1 | 0 | 1 | 0 | 0 | 2 |
| Median | 175 | 12 | 13 | 5 | 3 | |||||||
| BWS profile case | ||||||||||||
| Szeinbach et al. [ | USA | 1999 | 33 | 18 | 18 | 6 | 1 | 0 | 0 | 0 | 1 | 2 |
| Coast et al. [ | UK | 2006 | 96 | 9 | 16 | 4 | 1 | 0 | 1 | 1 | 1 | 4 |
| Coast et al. [ | UK | 2008 | 255 | 20 | 16 | 5 | 1 | 0 | 1 | 1 | 0 | 3 |
| Flynn et al. [ | UK | 2008 | 55 | 10 | 16 | 4 | 1 | 0 | 1 | 0 | 1 | 3 |
| Al-Janabi et al. [ | UK | 2011 | 162 | 18 | 18 | 6 | 1 | 0 | 1 | 0 | 1 | 3 |
| Potoglou et al. [ | UK | 2011 | 300 | 34 | 12 | 9 | 1 | 0 | 1 | 1 | 1 | 4 |
| Ratcliffe et al. [ | Australia | 2011 | 16 | 45 | 5 | 9 | 1 | 0 | 1 | 1 | 0 | 3 |
| Knox et al. [ | Australia | 2012 | 362 | 42 | 16 | 7 | 1 | 1 | 1 | 1 | 1 | 4 |
| Knox et al. [ | Australia | 2012 | 362 | 42 | 16 | 7 | 1 | 1 | 1 | 1 | 1 | 4 |
| Molassiotis et al. [ | UK | 2012 | 87 | 8 | 16 | 4 | 1 | 0 | 1 | 1 | 1 | 4 |
| Najafzadeh et al. [ | Canada | 2012 | 197 | 16 | 16 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| Netten et al. [ | UK | 2012 | 1296 | 32 | 8 | 8 | 1 | 1 | 1 | 0 | 1 | 4 |
| Ratcliffe et al. [ | Australia | 2012 | 590 | 45 | 10 | 9 | 1 | 0 | 1 | 0 | 1 | 3 |
| Severin et al. [ | Europe | 2013 | 26 | 13 | 12 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| Yoo and Dorion (1) [ | Australia | 2013 | 526 | 26 | 8 | 12 | 1 | 1 | 1 | 1 | 1 | 5 |
| Damery et al. [ | UK | 2014 | 132 | 12 | 9 | 4 | 1 | 0 | 1 | 1 | 1 | 4 |
| Hollin et al. [ | USA | 2014 | 119 | 18 | 18 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| Peay et al. [ | USA | 2014 | 119 | 18 | 18 | 6 | 1 | 0 | 1 | 0 | 1 | 3 |
| Ratcliffe [ | Australia | 2014 | 24 | 23 | 6 | 7 | 1 | 0 | 1 | 1 | 0 | 3 |
| Ungar et al. [ | Canada | 2014 | 101 | 16 | 16 | 6 | 1 | 0 | 1 | 1 | 1 | 4 |
| Whitty et al. [ | Australia | 2014 | 930 | 23 | 7 | 7 | 1 | 0 | 1 | 1 | 1 | 4 |
| dosReis et al. [ | USA | 2015 | 37 | 21 | 18 | 7 | 1 | 0 | 1 | 1 | 1 | 4 |
| Flynn et al. [ | UK | 2015 | 413 | 20 | 16 | 5 | 1 | 0 | 1 | 0 | 1 | 3 |
| Franco et al. [ | Australia | 2015 | 220 | 45 | 10 | 9 | 1 | 0 | 1 | 0 | 1 | 3 |
| Gendall et al. [ | New Zealand | 2015 | 534 | 15 | 10 | 3 | 1 | 0 | 1 | 1 | 0 | 4 |
| Jones et al. [ | Australia | 2015 | 31 | 10 | 32 | 4 | 1 | 1 | 1 | 1 | 1 | 5 |
| O’Hara et al. [ | South Africa | 2015 | 125 | 15 | 12 | 5 | 1 | 0 | 1 | 1 | 1 | 4 |
| Ratcliffe et al. [ | Australia | 2015 | 1190 | 45 | 10 | 9 | 1 | 0 | 1 | 0 | 0 | 2 |
| Tsao et al. [ | Canada | 2015 | 819 | 13 | 13 | 4 | 0 | 0 | 1 | 1 | 0 | 3 |
| Median | 162 | 18 | 16 | 6 | 4 | |||||||
| BWS multi-profile case | ||||||||||||
| Brown et al. [ | USA | 2011 | 53 | 36 | 12 | 12 | 1 | 0 | 1 | 1 | 1 | 4 |
| Hoek et al. [ | New Zealand | 2011 | 292 | 13 | 13 | 4 | 1 | 0 | 1 | 1 | 1 | 4 |
| Cameron et al. [ | Thailand | 2013 | 326 | 14 | 1 | 7 | 1 | 0 | 1 | 0 | 1 | 4 |
| Lancsar et al. [ | Canada | 2013 | 898 | 10 | 16 | 5 | 1 | 0 | 1 | 0 | 1 | 3 |
| Yoo and Doiron (2) [ | Australia | 2013 | 526 | 26 | 8 | 12 | 1 | 1 | 1 | 1 | 1 | 5 |
| Maubach et al. [ | New Zealand | 2014 | 768 | 14 | 9 | 4 | 1 | 0 | 1 | 1 | 1 | 4 |
| Xie et al. [ | Canada | 2014 | 100 | 25 | 11 | 5 | 1 | 0 | 1 | 1 | 1 | 4 |
| Median | 326 | 14 | 11 | 5 | 4 | |||||||
NA not applicable, NR not reported
aNumbers in parentheses represent 2 BWS studies described in the same article
bThe PREFS checklist criteria are Purpose, Respondents, Explanation, Findings, Significance
Characteristics of best–worst scaling (BWS) studies conducted in health care
| Item | Category | BWS object case | BWS profile case | BWS multi-profile case | |||
|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % | ||
| Target populationa | Health care professionals | 7 | 27 | 5 | 16 | 1 | 13 |
| Patients | 7 | 27 | 9 | 29 | 1 | 13 | |
| General population | 7 | 27 | 12 | 39 | 3 | 38 | |
| (Informal) caregivers | 3 | 12 | 4 | 13 | 1 | 13 | |
| Policy makers | 1 | 4 | 0 | 0 | 0 | 0 | |
| Other stakeholders | 1 | 4 | 1 | 3 | 2 | 25 | |
| Area of applicationa | Valuing health outcomes | 10 | 32 | 13 | 45 | 4 | 40 |
| Investigating trade-offs between health outcomes and patient or consumer experience factors | 8 | 26 | 4 | 14 | 0 | 0 | |
| Estimating utility weights within the quality-adjusted life-year framework | 2 | 6 | 1 | 3 | 4 | 40 | |
| Job choices | 0 | 0 | 3 | 10 | 1 | 10 | |
| Developing a priority-setting mechanism | 0 | 0 | 1 | 3 | 1 | 10 | |
| Health professionals’ preferences for treatment and screening options | 4 | 13 | 4 | 14 | 0 | 0 | |
| Other | 6 | 19 | 1 | 3 | 0 | 0 | |
| BWS design | Orthogonal main effects | 3 | 12 | 19 | 66 | 3 | 43 |
| Latin square (balanced order and pairing) | 2 | 8 | 0 | 0 | 0 | 0 | |
| Balanced incomplete block | 14 | 54 | 2 | 7 | 1 | 14 | |
| Full factorial | 2 | 8 | 2 | 7 | 0 | 0 | |
| Bayesian efficient | 1 | 4 | 2 | 7 | 1 | 14 | |
| Fractional other | 0 | 0 | 2 | 7 | 1 | 14 | |
| NR | 4 | 15 | 2 | 7 | 1 | 14 | |
| Domains of BWS factorsa | Money | 8 | 12 | 9 | 13 | 4 | 27 |
| Time | 6 | 9 | 7 | 10 | 1 | 7 | |
| Risk | 7 | 11 | 6 | 8 | 2 | 13 | |
| Health care | 16 | 24 | 17 | 24 | 3 | 20 | |
| Health status | 15 | 23 | 16 | 22 | 2 | 13 | |
| Other | 14 | 21 | 17 | 24 | 3 | 20 | |
| Analytical methoda | Hierarchical Bayes | 7 | 21 | 1 | 3 | 0 | 0 |
| Simple summary statistics (best-minus-worst summary statistics) | 11 | 32 | 8 | 24 | 0 | 0 | |
| MNL model | 4 | 12 | 16 | 47 | 5 | 63 | |
| Weighted least squares | 2 | 6 | 5 | 15 | 1 | 0 | |
| Latent class analysis | 3 | 9 | 1 | 3 | 0 | 13 | |
| Max diff scaling | 2 | 6 | 0 | 0 | 2 | 0 | |
| Ordered logit | 3 | 9 | 0 | 0 | 0 | 25 | |
| Random parameter logit model | 0 | 0 | 1 | 3 | 0 | 0 | |
| Qualitative; thinking aloud procedure | 2 | 6 | 0 | 0 | 0 | 0 | |
| NR | 7 | 21 | 1 | 3 | 0 | 0 | |
| Heterogeneity | No heterogeneity | 17 | 68 | 19 | 66 | 4 | 14 |
| Latent class | 2 | 8 | 6 | 21 | 0 | 0 | |
| Random parameter | 4 | 16 | 4 | 14 | 3 | 10 | |
| NR | 2 | 8 | 0 | 0 | 0 | 0 | |
| Software used for analyses of BWSa | Sawtooth software | 7 | 27 | 2 | 7 | 0 | 0 |
| SAS | 2 | 8 | 3 | 10 | 2 | 29 | |
| Stata | 2 | 8 | 9 | 31 | 1 | 14 | |
| Nlogit | 0 | 0 | 3 | 10 | 0 | 0 | |
| SPSS | 2 | 8 | 0 | 0 | 0 | 0 | |
| Latent Gold Choice | 0 | 0 | 2 | 7 | 0 | 0 | |
| NA/NR | 13 | 50 | 10 | 34 | 4 | 57 | |
Max diff maximum difference scaling, MNL multinomial logistic regression, NA not applicable, NR not reported
aMore than one category per BWS study was possible
Trend analysis
| BWS object case | BWS profile case | BWS multi-profile case | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | Min | Max |
| Median | Min | Max |
| Median | Min | Max |
| |
| Number of included factors | ||||||||||||
| ≤2010 | 15 | 15 | 15 | 1 | 14 | 9 | 20 | 4 | 0 | 0 | 0 | 0 |
| 2011 | 11 | 11 | 11 | 2 | 34 | 18 | 45 | 3 | 24.5 | 13 | 36 | 2 |
| 2012 | 11 | 11 | 15 | 3 | 37 | 8 | 45 | 6 | 0 | 0 | 0 | 0 |
| 2013 | 39 | 39 | 39 | 1 | 19.5 | 13 | 26 | 2 | 14 | 10 | 26 | 3 |
| 2014 | 14 | 9 | 53 | 9 | 18 | 12 | 23 | 6 | 19.5 | 14 | 25 | 2 |
| 2015 | 12 | 6 | 16 | 10 | 17.5 | 10 | 45 | 8 | 0 | 0 | 0 | 0 |
| Number of factors per choice task | ||||||||||||
| ≤2010 | 8 | 8 | 8 | 1 | 4.5 | 4 | 6 | 4 | 0 | 0 | 0 | 0 |
| 2011 | 4 | 4 | 4 | 2 | 9 | 6 | 9 | 3 | 8 | 4 | 12 | 2 |
| 2012 | 5 | 5 | 11 | 3 | 7 | 4 | 9 | 6 | 0 | 0 | 0 | 0 |
| 2013 | NR | NR | NR | 1 | 9 | 6 | 12 | 2 | 7 | 5 | 12 | 3 |
| 2014 | 5 | 3 | 6 | 9 | 6 | 4 | 7 | 6 | 4.5 | 4 | 5 | 2 |
| 2015 | 4.5 | 3 | 6 | 10 | 5 | 3 | 9 | 8 | 0 | 0 | 0 | 0 |
| Number of choice tasks | ||||||||||||
| ≤2010 | 15 | 15 | 15 | 1 | 16 | 16 | 18 | 4 | 0 | 0 | 0 | 0 |
| 2011 | NR | NR | NR | 2 | 12 | 5 | 18 | 3 | 12.5 | 12 | 13 | 2 |
| 2012 | 11 | 11 | 16 | 3 | 16 | 8 | 16 | 6 | 0 | 0 | 0 | 0 |
| 2013 | NR | NR | NR | 1 | 10 | 8 | 12 | 2 | 8 | 1 | 16 | 3 |
| 2014 | 14 | 5 | 20 | 9 | 12.5 | 6 | 18 | 6 | 10 | 9 | 11 | 2 |
| 2015 | 12.5 | 10 | 16 | 10 | 12.5 | 10 | 32 | 8 | 0 | 0 | 0 | 0 |
| Sample size | ||||||||||||
| ≤2010 | 204 | 204 | 204 | 1 | 75.5 | 33 | 255 | 4 | 0 | 0 | 0 | 0 |
| 2011 | 184 | 164 | 204 | 2 | 162 | 16 | 300 | 3 | 172.5 | 53 | 292 | 2 |
| 2012 | 168 | 120 | 376 | 3 | 362 | 87 | 1296 | 6 | 0 | 0 | 0 | 0 |
| 2013 | 367 | 367 | 367 | 1 | 276 | 26 | 526 | 2 | 526 | 326 | 898 | 3 |
| 2014 | 206 | 15 | 803 | 9 | 119 | 24 | 930 | 6 | 434 | 100 | 768 | 2 |
| 2015 | 150.5 | 25 | 603 | 10 | 316.5 | 31 | 1190 | 8 | 0 | 0 | 0 | 0 |
BWS best–worst scaling, Max maximum, Min minimum, NR not reported
Fig. 4Analytical methods used per year: a best–worst scaling (BWS) object case, b BWS profile case and c BWS multi-profile case. Max diff maximum difference scaling, MNL multinomial logistic regression, NR not reported
| This systematic review identified 62 best–worst scaling (BWS) studies conducted in health care and published up until April 2016. About two thirds of the studies were performed in the last 2 years, indicating the increasing popularity of the method. |
| BWS is an attractive and relatively easy method to investigate preferences over a wide range of health care topics. |
| Most BWS studies in this review were of acceptable quality according to the PREFS checklist. However, researchers should give more attention to reporting whether responders are similar to non-responders in a study. This may reduce the risk of bias and increase the generalisability of the findings. |